Literature DB >> 15062575

Mixed lineage kinase 2 enhances trans-repression of Alien and nuclear receptors.

Maren Eckey1, Stephan P Tenbaum, Alberto Muñoz, Aria Baniahmad.   

Abstract

Alien was previously identified as a corepressor for the thyroid hormone receptor (TR) and DAX-1 which belong both to the superfamily of nuclear receptors. Here, we isolated the mixed lineage kinase 2 (MLK2) as an interacting partner for the corepressor Alien using a yeast two hybrid screen. MLK2 is an upstream activator of JNKs and activation of MLK2-mediated signaling cascades play roles in neurodegenerative and apoptotic mechanisms in the central nervous system. MLK2 has been shown to be localized both in the cytoplasm and cell nucleus. We confirmed the Alien-MLK2 interaction using GST pull-down experiments and also show that MLK2 is able to phosphorylate Alien in immune-kinase assays. Functional analyses revealed that Alien, DAX-1 and thyroid hormone receptor mediated transcriptional silencing is strongly enhanced in the presence of active MLK2. Since MAP kinase signaling pathways are important mediators of cellular responses to a wide variety of stimuli, our data suggest that signaling pathways not only regulate transactivation but also enhancement of transcriptional silencing. This novel cross-talk may represent a link between MLK2-mediated signaling and transcriptional repression of target genes during neuronal differentiation processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15062575     DOI: 10.1016/j.mce.2003.10.035

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  The nucleosome assembly activity of NAP1 is enhanced by Alien.

Authors:  Maren Eckey; Wei Hong; Maria Papaioannou; Aria Baniahmad
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

2.  Mixed lineage kinase phosphorylates transcription factor E47 and inhibits TrkB expression to link neuronal death and survival pathways.

Authors:  Neus Pedraza; Marta Rafel; Isis Navarro; Mario Encinas; Martí Aldea; Carme Gallego
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.